Stockscreener 앱 받기
2.28
2.70%
0.06
시간 외 거래:
2.28
전일 마감가:
$2.22
열려 있는:
$2.17
하루 거래량:
16,804
Relative Volume:
0.81
시가총액:
$7.05M
수익:
$4.33M
순이익/손실:
$-4.17M
주가수익비율:
-1.5248
EPS:
-1.4953
순현금흐름:
$-3.19M
1주 성능:
+5.56%
1개월 성능:
+7.04%
6개월 성능:
-9.88%
1년 성능:
-36.31%
1일 변동 폭
$2.15
$2.28
1주일 범위
$2.14
$2.28
52주 변동 폭
$1.8664
$4.60
Biomerica Inc Stock (BMRA) Company Profile
명칭
Biomerica Inc
전화
(949) 379-2875
주소
17571 VON KARMAN AVENUE, IRVINE, CA
Compare BMRA vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
2.28 | 6.86M | 4.33M | -4.17M | -3.19M | -1.4953 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-11-10 | 개시 | Colliers Securities | Buy |
| 2018-01-04 | 개시 | B. Riley FBR, Inc. | Buy |
Biomerica Inc 주식(BMRA)의 최신 뉴스
TradingKey - TradingKey
BMRA | BIOMERICA INC Insider Trading - Quiver Quantitative
How Biomerica (BMRA) competitive position is evolving (Bullish Momentum) 2026-05-06Cycle Analysis - newser.com
Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026 - Weekly Voice
An IBS diet-guided therapy gets a slot at the world's biggest GI meeting - Stock Titan
BMRA (Biomerica) falls 0.47% after reporting Q1 2026 negative EPS of $-0.44 with no available analyst consensus estimates.Social Buy Zones - newser.com
BMRA (Biomerica Inc.) slips 0.91% following Q1 2026 earnings release with no available analyst consensus estimates.Hedge Fund Inspired Picks - Xã Thanh Hà
BMRA (Biomerica Inc.) posts 1.9 percent year-over-year Q1 2026 revenue dip, shares gain 4.27 percent. - Cổng thông tin điện tử tỉnh Lào Cai
Biomerica Q3 Sales Fall, Net Loss Widens Amid Restructuring - Orange County Business Journal
BMRA Biomerica reports 1.9% year-over-year Q1 2026 revenue decline, shares drop 2.52% in today’s session.Trending Stock Ideas - newser.com
Biomerica (BMRA) Stock Bid Wall (Near Lows) 2026-04-18Top Trending Breakouts - newser.com
BMRA Stock Price, Quote & Chart | BIOMERICA INC (NASDAQ:BMRA) - ChartMill
Biomerica (BMRA) Secures Medicare Coverage for inFoods IBS Tests - GuruFocus
Biomerica, Inc. Receives Medicare Confirmation for inFoods® IBS Claims Processing Pathway - Quiver Quantitative
Biomerica Inc Announces Medicare Administrative Contractor Confirmation of Individual Claim Review For Infoods Ibs Test - marketscreener.com
Biomerica (BMRA) Stock Bonus Issue (Investor Interest) 2026-04-15Trader Community Insights - Cổng thông tin điện tử Tỉnh Sơn La
Biomerica, Inc., Phoenix Airmid Biomedical And CanAlt Health Labs Launch inFoods IBS Platform In Canada - marketscreener.com
Biomerica reports net loss of USD 1.31M in Q3 2026 - Medical Buyer
Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs - The Manila Times
Up to 5 million Canadians have IBS; Biomerica brings inFoods north - Stock Titan
Biomerica's Q3 revenue falls, net loss widens on lower manufacturing sales - TradingView
Biomerica Reports Third Quarter Fiscal 2026 Financial Results - Weekly Voice
Biomerica Reports Third Quarter Fiscal 2026 Financial Results, Highlights Real-World Efficacy of inFoods® IBS and Growth in European Revenue - Quiver Quantitative
BRIEF-Biomerica Q3 Net Income USD -1.31 Million - TradingView
Press Release: Biomerica Reports Third Quarter Fiscal 2026 Financial Results - Moomoo
Biomerica 10-Q: Revenue $0.99M, EPS $(0.44) for Q3 ended Feb 28, 2026 - TradingView
Biomerica (BMRA) revenue falls 22% as losses persist and going concern risk disclosed - Stock Titan
Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 - marketscreener.com
Update Report: Will Biomerica Inc stock benefit from M A2026 Earnings Impact & Weekly Stock Breakout Alerts - baoquankhu1.vn
Aug Breakouts: Is Biomerica Inc a strong candidate for buy and holdMarket Volume Summary & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Press Releases about Biomerica, Inc.Common Stock (Nasdaq:BMRA) - FinancialContent
How does Biomerica (BMRA) Stock compare to competitors | Price at $2.16, Up 0.47%Institutional Grade Stocks - newser.com
Biomerica (BMRA) to Post Earnings on Monday - Defense World
BMRA: BiomericaInteractive Chart - Zacks Investment Research
Is Biomerica (BMRA) Stock Moving Sideways | Price at $2.17, Down 0.91%Expert Entry Points - newser.com
Should value investors consider Biomerica Inc2026 Price Targets & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
AI Stocks: Whats the fair value of Biomerica Inc stockMarket Risk Report & Fast Gain Swing Alerts - baoquankhu1.vn
Rate Hike: What is the PEG ratio of Biomerica Inc2026 EndofYear Setup & Stock Portfolio Risk Management - baoquankhu1.vn
BMRA PE Ratio & Valuation, Is BMRA Overvalued - intellectia.ai
Biomerica gets first commercial order for H pylori test - MSN
Biomerica Receives First Commercial Order for its H. pylori test from one of the Largest Clinical Laboratory Chains in Europe - marketscreener.com
Biomerica (BMRA) Secures First European Order for H. pylori Test - GuruFocus
First European commercial order landed: US diagnostic product company Biomerica announces that its Helicobacter pylori detection product HP Detect™ has received the first commercial order from one of Europe's largest clinical laboratory chains. - Bitget
Biomerica Secures First Commercial Order for Hp Detect™ from Major European Laboratory Chain - Quiver Quantitative
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect) from One of the Largest Clinical Laboratory Chains in Europe - Bitget
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe - marketscreener.com
Stomach cancer bacteria drives major lab’s first order of Hp Detect test - Stock Titan
Earnings Miss: Is Biomerica Inc stock a value trap2025 Top Decliners & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Biomerica receives UK regulatory approval for H. pylori test - Investing.com
Biomerica receives UK regulatory approval for H. pylori test By Investing.com - Investing.com Nigeria
Biomerica (BMRA) Expands Market with UK Approval for hp+detect T - GuruFocus
Biomerica Inc (BMRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.34%
자본화:
|
볼륨(24시간):